Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases

Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases

US Patent 12410190 · Granted Sep 9, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Clock control method and electronic device thereof2025
Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,2025
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alp2025
Address conversion system and address conversion method2025
Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors2025
Immunoproteasome inhibitors2025
Displaying content transmitted by an external device based on detection of a con2025
Alkaline cleaning composition, cleaning method, and manufacturing method of semi2025
Bluetooth audio broadcasting system and related multi-member bluetooth device su2025
Bluetooth audio broadcasting system supporting Bluetooth low energy audio broadc2025
Bluetooth audio broadcasting system supporting Bluetooth low energy audio broadc2025
Bluetooth voice communication system and related computer program product for ge2025